DIFFERENTIAL METHYLATION AS A POTENTIAL BIOMARKER OF METHOTREXATE RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：1
|
作者：
Nair, N. [1 ,2 ]
Plant, D. [1 ,2 ,3 ]
Verstappen, S. M. [1 ,2 ]
Isaacs, J. D. [4 ,5 ]
Morgan, A. W. [6 ]
Hyrich, K. L. [1 ,2 ]
Barton, A. [1 ,2 ]
Wilson, A. G. [7 ]
机构：
[1] Univ Manchester, Arthrit Res UK Ctr Genet & Genom, Manchester, Lancs, England
[2] Univ Manchester, Genom & Ctr Epidemiol, Manchester, Lancs, England
[3] CMFT, NIHR Manchester Musculoskeletal BRU, Manchester, Lancs, England
[4] Newcastle Upon Tyne Hosp NHS Fdn Trust, NIHR Newcastle BRU, Newcastle Upon Tyne, Tyne & Wear, England
[5] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
[6] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[7] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.6330
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0001
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [41] Evaluation of levels of oxidative stress as a potential biomarker in patients with rheumatoid arthritis
    Mukhopadhyay, Kaushik
    De, Soumita
    Kundu, Sunanda
    Ghosh, Parasar
    Chatterjee, Suparna
    Chatterjee, Mitali
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (05) : 1981 - 1986
  • [42] Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY
    Boyapati, Anita
    Msihid, Jerome
    Fiore, Stefano
    van Adelsberg, Janet
    Graham, Neil M. H.
    Hamilton, Jennifer D.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [43] Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY
    Anita Boyapati
    Jérôme Msihid
    Stefano Fiore
    Janet van Adelsberg
    Neil M. H. Graham
    Jennifer D. Hamilton
    Arthritis Research & Therapy, 18
  • [44] Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression
    Nishina, Naoshi
    Kaneko, Yuko
    Kameda, Hideto
    Kuwana, Masataka
    Takeuchi, Tsutomu
    CLINICAL RHEUMATOLOGY, 2013, 32 (11) : 1661 - 1666
  • [45] Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression
    Naoshi Nishina
    Yuko Kaneko
    Hideto Kameda
    Masataka Kuwana
    Tsutomu Takeuchi
    Clinical Rheumatology, 2013, 32 : 1661 - 1666
  • [46] Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker
    Yong Gil Hwang
    Goundappa K. Balasubramani
    Ilinca D. Metes
    Marc C. Levesque
    S. Louis Bridges
    Larry W. Moreland
    Arthritis Research & Therapy, 18
  • [47] Seropositivity-Dependent Association between LINE-1 Methylation and Response to Methotrexate Therapy in Early Rheumatoid Arthritis Patients
    Ravaei, Amin
    Pulsatelli, Lia
    Assirelli, Elisa
    Meliconi, Riccardo
    Ciaffi, Jacopo
    Gremese, Elisa
    Tolusso, Barbara
    Salvarani, Carlo
    Govoni, Marcello
    Rubini, Michele
    GENES, 2022, 13 (11)
  • [48] Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker
    Hwang, Yong Gil
    Balasubramani, Goundappa K.
    Metes, Ilinca D.
    Levesque, Marc C.
    Bridges, S. Louis, Jr.
    Moreland, Larry W.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [49] Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients
    Koeller, Marcus D.
    Aletaha, Daniel
    Funovits, Julia
    Pangan, Aileen
    Baker, Daniel
    Smolen, Josef S.
    RHEUMATOLOGY, 2009, 48 (12) : 1575 - 1580
  • [50] BIOMARKER CHANGES FOR PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB WITH METHOTREXATE OR GLUCOCORTICOIDS VS TOFACITINIB MONOTHERAPY
    Lee, Julie
    Chen, Xing
    Zhang, Weidong
    Martin, David
    Hyde, Craig
    Hirose, Tomohiro
    Shah, Shweta
    Fitz, Lori
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1500 - 1500
12345